"通过结构化临床文档和生物信号衍生的表型合成来促进心血管风险识别"项目:概念设计,项目规划和首次实施经验.
Dominik Felbel1, Merten Prüser2,3, Constanze Schmidt4
1Department of Cardiology, Ulm University Heart Center, Ulm, Germany.
European heart journal. Digital health
|September 23, 2025
概括
该ACRIBiS项目通过整合常规临床数据和高分辨率生物信号来加强心血管风险评估. 这通过标准化数据和创新工具来改善个性化的预防和患者赋权.
科学领域:
- 心血管医学 心血管医学
- 医疗信息学医学信息学
- 健康数据的互操作性
背景情况:
- 个性化风险评估工具 (PRT) 对于心血管保健至关重要,但临床实施不佳.
- 有效的PRT需要标准化的文档和生物信号集成.
研究的目的:
- 为标准化临床文档和高分辨率生物信号 (HRB) 集成建立可互操作的基础设施.
- 为了使基于数据的心血管风险评估,并改善患者的赋权和预后.
主要方法:
- 选择了已建立的心血管风险得分,并建立了一个核心数据集,其中包含与风险相关的临床信息.
- 开发了互操作性的扩展模块,并实施了用于HRB集成的模块化ECG处理基础设施.
- 在12个月的5250名患者队列中使用HRB集成评估PRT预测性能和动态重新校准.
主要成果:
- 该ACRIBiS项目协调了临床数据文档,并整合了ECG数据,以加强风险评估.
- 制定了基于共识的规范,用于标准化的例行患者数据收集.
- ACRIBiS队列数据集将可用于广泛的二次使用.
结论:
- 该ACRIBiS项目通过协调数据和生物信号集成,促进个性化心血管风险评估.
- 标准化文档和互操作性规范支持国家和国际数据收集.
- 该项目旨在改善患者赋权和心血管预后.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
801
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
801
Assessment of the Cardiovascular System I: Subjective Data
757
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
757
Coronary Artery Disease I: Introduction
890
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
890
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
364
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
364
Cardiomyopathy III: Hypertrophic Cardiomyopathy
414
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
414


